In lipopolysaccharide (LPS)-induced AKI, miR-155 inhibition reduced STAT3 phosphorylation, inflammation, and apoptosis, highlighting its role in septic AKI (Ren et al., 2017). The gene discussed is STAT3; the disease is acute kidney injury.